NAMS – newamsterdam pharma company n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March
The Bull Case For NewAmsterdam Pharma (NAMS) Could Change Following 2025 Results And New Share Offering [Yahoo! Finance]
NewAmsterdam Pharma (NASDAQ:NAMS) was downgraded by analysts at Wall Str
NewAmsterdam Pharma (NASDAQ:NAMS) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
NewAmsterdam Pharma (NASDAQ:NAMS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Form 4 NewAmsterdam Pharma Co For: Feb 20 Filed by: Kastelein Johannes Jacob Pieter
Form 144 NewAmsterdam Pharma Co Filed by: Davidson Michael H.
Form 144 NewAmsterdam Pharma Co Filed by: Kastelein Johannes Jacob Pieter
Form S-8 NewAmsterdam Pharma Co
Form 10-K NewAmsterdam Pharma Co For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.